Skip to main content
DNA Labs India

LARS2 Gene Perrault syndrome type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

LARS2 Gene Perrault syndrome type 4 NGS Genetic Test

Short Name: LARS2 NGS

Also known as: Perrault Syndrome Type 4 Genetic Test, LARS2 Gene Mutation Test, LARS2 NGS Genetic Test

LARS2 Gene Perrault syndrome type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are usually available 3 to 4 weeks after the sample reaches the laboratory. You will receive an SMS or email notification when the report is ready.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this NGS genetic test is to identify clinically significant variants in the LARS2 gene in a patient presenting with features of Perrault syndrome type 4. It also helps to confirm a clinical diagnosis, distinguish LARS2-related disease from other hereditary hearing loss and neurological syndromes, guide surveillance and management, and provide accurate recurrence risk and carrier risk information for family members.

Test Code
4458
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are usually available 3 to 4 weeks after the sample reaches the laboratory. You will receive an SMS or email notification when the report is ready.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. Please carry a valid ID, the completed clinical history form, any audiology or ophthalmology reports, and family pedigree information if available. A pre-test genetic counselling session will be arranged before sample submission.

Method: Venous blood draw or dried blood spot on FTA card

Step 2

Laboratory Analysis

A trained phlebotomist will collect 2-4 mL of venous blood in an EDTA tube or prepare a dried blood spot on an FTA card. The procedure is quick and takes less than 10 minutes.

Step 3

Report Delivery

There are no restrictions after sample collection. You may resume your normal activities. Keep your requisition form number to track the status of your report.

Timeline: Reports are usually available 3 to 4 weeks after the sample reaches the laboratory. You will receive an SMS or email notification when the report is ready.

Patient Instructions

1
Before the Test:No fasting is required. Carry a valid ID, clinical history, family pedigree data and prior audiology/ophthalmology reports. A genetic counselling session will be arranged before sample collection.
2
During the Test:A blood sample or FTA card blood spot will be collected. The test itself is performed in the laboratory using next-generation sequencing technology.
3
After the Test:No dietary or activity restrictions. The laboratory will share the report through your preferred mode when available. A genetic counsellor can explain the results once the report is issued.

About This Test

Who Should Get This Test

The primary purpose of this NGS genetic test is to identify clinically significant variants in the LARS2 gene in a patient presenting with features of Perrault syndrome type 4. It also helps to confirm a clinical diagnosis, distinguish LARS2-related disease from other hereditary hearing loss and neurological syndromes, guide surveillance and management, and provide accurate recurrence risk and carrier risk information for family members.

How to Prepare

  • Sample should be labeled clearly with the patient name, date of birth and collection date
  • For home collection, keep the sample kit at room temperature until pickup
  • Do not freeze whole blood
  • FTA card should be air-dried and protected from moisture and direct sunlight

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Diagnosis of Perrault syndrome type 4 requires combined clinical, audiological, ophthalmological and gynecological evaluation in females. Genetic confirmation helps in family counseling and early surveillance."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeEDTA blood: 2-4 mL; FTA card: 1 spot; extracted DNA: 2-3 μg
ContainerEDTA lavender-top tube / DNA storage tube / Dried blood spot card
Collection MethodVenous blood draw or dried blood spot on FTA card

Sample Stability

Whole blood in EDTA: 24-48 hours at 2-8°C
Extracted DNA: stable for 7 days at 2-8°C; long-term storage at -20°C
FTA card: stable at room temperature for several weeks if kept dry
Sample Rejection Criteria:
  • Clotted or hemolyzed EDTA blood sample
  • Sample received without proper labeling
  • Insufficient DNA quantity or quality for NGS
  • Requisition form missing clinical details or patient identifiers

Understanding Your Results

This is a single-gene NGS test for LARS2-related Perrault syndrome type 4. The report should be interpreted in the context of the patient's clinical features, family history and other diagnostic findings.
📊

Pathogenic or likely pathogenic variant identified

Consistent with a clinical diagnosis of Perrault syndrome type 4. Confirmatory parental testing is recommended for recurrence risk assessment.

📊

Variant of uncertain significance (VUS) identified

The clinical significance of the variant is unclear. Family segregation studies and further clinical evaluation may help clarify its role.

📊

No pathogenic or likely pathogenic variant identified

Does not exclude LARS2-related Perrault syndrome type 4. Clinical correlation and evaluation of other Perrault syndrome genes or broader exome testing may be considered.

⚠️ When to Consult a Doctor:

Consult a neurologist, clinical geneticist or gynecologist if you or a family member have early-onset hearing loss, visual failure, ataxia, learning difficulty or premature ovarian insufficiency. Genetic counselling is also recommended before and after genetic testing to understand the results and reproductive implications.

Limitations

  • This test is targeted to the LARS2 gene and does not rule out other genetic causes of Perrault syndrome
  • NGS may not detect all types of mutations, including large deletions/duplications, in every case
  • A negative result does not completely exclude LARS2-related Perrault syndrome type 4
  • Clinical correlation and additional testing are recommended when symptoms are strongly suggestive
  • Results should be interpreted by a qualified clinical geneticist or genetic counsellor

Risks & Considerations

  • Venipuncture may cause transient pain, bruising or swelling at the puncture site
  • Fainting or light-headedness during blood collection is uncommon but possible
  • Genetic test results may have implications for family members; this should be discussed with a genetic counsellor

Interfering Factors

  • Poor DNA quantity or quality may reduce sequencing coverage
  • Contamination during sample collection can affect result accuracy
  • Rare deep intronic variants or large structural rearrangements may not be detected by standard NGS
  • Variants of uncertain significance may not provide a definitive diagnosis without family studies

Compare With Similar Tests

TestLARS2 Gene Perrault syndrome type 4 NGS Genetic Test
ComparisonLARS2 Gene Perrault syndrome type 4 NGS Genetic Test

Frequently Asked Questions

What is Perrault syndrome type 4?
Perrault syndrome type 4 is a rare genetic condition associated with mutations in the LARS2 gene. It can affect hearing, vision, balance, neurological development and, in females, ovarian function. The condition varies in severity and is diagnosed by clinical evaluation and genetic testing.
What is the LARS2 gene?
LARS2 provides instructions for making mitochondrial leucyl-tRNA synthetase, an enzyme needed for protein production and energy generation in mitochondria. Pathogenic variants in LARS2 can disrupt mitochondrial function, leading to symptoms seen in Perrault syndrome type 4.
Who should consider this test?
Individuals with bilateral sensorineural hearing loss, optic atrophy, ataxia or balance problems, learning difficulties, premature ovarian insufficiency, or a family history suggestive of Perrault syndrome should discuss testing with their neurologist, clinical geneticist or gynecologist.
What does this NGS genetic test include?
This test uses next-generation sequencing to analyze the LARS2 gene for disease-causing variants. The report includes clinical interpretation and, as per DNA Labs India policy, raw data files such as FASTQ and VCF are shared for transparency.
Is fasting required for this test?
No, this is a genetic test and does not require fasting. You can eat and drink normally before sample collection.
What types of samples are accepted?
The test can be performed on whole blood in an EDTA tube, extracted DNA, or one drop of blood applied on an FTA card. You can choose the most convenient method during booking.
How long will the report take?
Results are generally generated in 3 to 4 weeks after the sample reaches the laboratory. The exact time can depend on sequencing run schedules and sample quality.
What does a negative result mean?
A negative result means no pathogenic or likely pathogenic variant was identified in the LARS2 gene. However, it does not completely rule out LARS2-related disease; clinical correlation and additional genetic testing may be needed.
Can this test identify variants of uncertain significance?
Yes. NGS can detect variants whose clinical significance is not yet clear. Such variants are reported according to ACMG-like classification, and family segregation studies may be recommended to help interpret them.
Does this test detect ovarian abnormalities?
The test detects genetic variants in LARS2 that can cause Perrault syndrome type 4, which may include ovarian dysfunction in females. Genetic testing itself does not assess ovarian structure; ultrasound and hormone evaluation are needed for clinical characterization.
Is genetic counselling offered with this test?
Yes, a pre-test genetic counselling session is carried out to draw a pedigree and document family history. After the report, patients are encouraged to discuss the result with the ordering physician or the laboratory's genetic counselors.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings in many cities across India. The test price of INR 20,000 includes home collection at the discounted rate.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.